Search Results

KO The Coca-Cola Company - Fundamental Analysis

NEUTRAL
KO Stock | Fundamental Analysis & Investment Insights
NYSE Consumer Defensive Beverages - Non-Alcoholic
Current Price
$69.12
Analyst Target
$79.61
+15.2% Upside
52W High
$74.38
52W Low
$60.62

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 04, 2026
Market cap
$297.47B
P/E
22.89
ROE
42.4%
Profit margin
27.3%
Debt/Equity
1.45
Dividend yield
2.95%

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
72%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a mixed health profile: the Piotroski F-Score of 3/9 indicates weak financial health, while the Altman Z-Score of 458439474892.8 suggests an extremely low distress risk, bordering on statistical anomaly. Despite strong profitability metrics and a solid dividend yield, elevated valuation multiples, insider selling, and weakening near-term earnings growth temper optimism. The stock trades above the Graham Number of $22.22 and below the growth-based intrinsic value of $89.09, reflecting a premium for stability and brand strength. However, recent bearish technical trends and declining short-term momentum suggest caution despite long-term resilience.

Key Strengths

Exceptionally high Altman Z-Score indicating virtually no bankruptcy risk
Strong profitability with ROE of 42.44%, ROA of 8.96%, and gross margin of 61.63%
Consistent earnings beat history — 22 out of 25 quarters exceeded estimates
Attractive dividend yield of 2.95% with a sustainable payout ratio of 66.72%
Revenue and earnings growth accelerating year-over-year at 5.10% and 30.10% respectively

Key Risks

Low Piotroski F-Score of 3/9 signals weak financial health and operational deterioration
Elevated valuation with P/E of 22.89 and Price/Book of 9.52 above sector averages
Insider selling activity totaling $18.54M in the last 6 months indicates lack of confidence
Bearish technical trend score of 0/100 and recent price underperformance over 6M and 1M
Most recent Q/Q EPS growth declined by 5.7%, indicating near-term earnings deceleration
AI Fair Value Estimate
Based on comprehensive analysis
$82.5
+19.4% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
61
Strong
Value
55
Future
65
Past
70
Health
40
Dividend
75
AI Verdict
Neutral with upside potential if execution improves
Key drivers: High profitability and dividend appeal, Exceptional Altman Z-Score, Rich valuation and weak Piotroski score as headwinds, Insider selling pressure, Analyst target implies 15% upside
Confidence
75%
Value
55/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 22.89 is below sector average of 23.83
  • Forward P/E of 21.46 suggests modest de-rating expected
Watchpoints
  • Price/Book of 9.52 is very high
  • Current price ($69.12) is 210% above Graham Number ($22.22)
  • No PEG ratio due to inconsistent growth trajectory
Future
65/100

Ref Growth rates

Positives
  • YoY earnings growth of 30.10% is robust
  • Revenue growth of 5.10% is stable
Watchpoints
  • Q/Q EPS growth declined by 5.7%
  • No Q/Q revenue data available, raising transparency concerns
Past
70/100

Ref Historical trends

Positives
  • 22 out of 25 quarters beat EPS estimates
  • Average earnings surprise of +3.73% over last 4 quarters
  • Long-term price appreciation: +52.3% over 5 years
Watchpoints
  • Recent 6M and 1M returns are negative
  • Most recent quarter missed estimates (-1.1%)
Health
40/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Altman Z-Score of 458439474892.8 is astronomically high, indicating no distress risk
  • Operating margin of 32.37% reflects pricing power
Watchpoints
  • Piotroski F-Score of 3/9 indicates weak financial health
  • Debt/Equity of 1.45 is high, though below sector average of 1.97
  • Quick ratio of 0.88 suggests liquidity pressure
Dividend
75/100

Ref Yield, Payout

Positives
  • Dividend yield of 2.95% is attractive in current rate environment
  • Payout ratio of 66.72% is manageable for a mature firm
  • Dividend strength score of 50/100 indicates moderate reliability
Watchpoints
  • No 5-year average yield provided, limiting trend analysis

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$69.12
Analyst Target
$79.61
Upside/Downside
+15.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for KO and closest competitors.

Updated 2026-01-02
Company 5Y 3Y 1Y 6M 1M 1W
KO
The Coca-Cola Company
Primary
+52.3% +20.2% +15.1% -1.7% -2.4% -1.1%
PG
The Procter & Gamble Company
Peer
+16.6% +0.9% -12.3% -10.6% -3.4% -2.0%
PM
Philip Morris International Inc.
Peer
+153.1% +89.2% +25.8% -7.3% -1.5% +1.3%
COST
Costco Wholesale Corporation
Peer
+137.6% +96.4% -5.6% -13.2% -7.3% -2.2%
PEP
PepsiCo, Inc.
Peer
+15.0% -12.5% -1.5% +7.1% -3.0% -1.1%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
22.89
Forward P/E
21.46
PEG Ratio
N/A
P/B Ratio
9.52
P/S Ratio
6.24
EV/Revenue
6.96
EV/EBITDA
20.34
Market Cap
$297.47B

Profitability

Profit margins and return metrics

Profit Margin 27.34%
Operating Margin 32.37%
Gross Margin 61.63%
ROE 42.44%
ROA 8.96%

Growth

Revenue and earnings growth rates

Revenue Growth +5.1%
Earnings Growth +30.1%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +29.8%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
1.45
Moderate
Current Ratio
1.21
Good
Quick Ratio
0.88
Poor
Cash/Share
$3.67

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-10
$N/A
2025-10-21
$0.82
+5.3% surprise
2025-07-22
$0.87
+3.9% surprise
2025-04-29
$0.73
+1.9% surprise

Consumer Defensive Sector Comparison

Comparing KO against 16 companies in the Consumer Defensive sector (2 bullish, 13 neutral, 1 bearish)
P/E Ratio
22.89
This Stock
vs
24.87
Sector Avg
-8.0% (Discount)
Return on Equity (ROE)
42.44%
This Stock
vs
50.96%
Sector Avg
-16.7% (Below Avg)
Profit Margin
27.34%
This Stock
vs
10.39%
Sector Avg
+163.1% (Superior)
Debt to Equity
1.45
This Stock
vs
1.82
Sector Avg
-20.6% (Less Debt)
Revenue Growth
5.1%
This Stock
vs
5.11%
Sector Avg
-0.2% (Slower)
Current Ratio
1.21
This Stock
vs
1.05
Sector Avg
+15.5% (Stronger)

Similar Companies

Peer comparison within the same industry

Company AI Rating Market Cap P/E ROE Profit Margin Price
KO
The Coca-Cola Company
NEUTRAL $297.47B 22.89 42.4% 27.3% $69.12
PG
The Procter & Gamble Company
NEUTRAL $331.86B 20.7 31.9% 19.7% $141.79
PM
Philip Morris International Inc.
BULLISH $241.95B 22.17 -% 21.6% $155.43
COST
Costco Wholesale Corporation
NEUTRAL $379.36B 45.87 30.3% 3.0% $854.5
PEP
PepsiCo, Inc.
NEUTRAL $194.72B 27.04 37.2% 7.8% $142.23

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

Date Insider Position Transaction Shares Value
2025-11-17 QUAN NANCY W Officer Option Exercise 31,625 $1,373,632
2025-11-17 QUAN NANCY W Officer Sale 31,625 $2,250,805
2025-11-14 ARROYO MANUEL Officer Sale 139,689 $9,890,610
2025-11-11 BRAUN HENRIQUE GNANI Chief Operating Officer Option Exercise 50,545 $2,199,466
2025-11-11 BRAUN HENRIQUE GNANI Chief Operating Officer Sale 40,390 $2,864,915
2025-10-29 MURPHY JOHN President Gift 33,000 -
2025-10-24 DOUGLAS MONICA HOWARD Officer Option Exercise 13,548 $568,245
2025-10-24 DOUGLAS MONICA HOWARD Officer Sale 13,548 $947,464
2025-10-24 LEVCHIN MAX R Director Purchase 14,267 $998,676
2025-08-05 KOUMETTIS NIKOLAOS Divisional Officer Sale 37,396 $2,584,105
2025-08-04 PEREZ BEATRIZ R Officer Gift 43,847 -
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
23 analysts
B of A Securities
2025-11-07
Maintains
Buy Buy
Barclays
2025-10-23
Maintains
Overweight Overweight
TD Cowen
2025-10-22
Maintains
Buy Buy
Piper Sandler
2025-10-22
Maintains
Overweight Overweight
Wells Fargo
2025-10-22
Maintains
Overweight Overweight
Wells Fargo
2025-09-25
Maintains
Overweight Overweight
UBS
2025-09-11
Maintains
Buy Buy
UBS
2025-07-23
Maintains
Buy Buy
JP Morgan
2025-07-23
Maintains
Overweight Overweight
BNP Paribas
2025-07-21
reit
Outperform Outperform